Skip to content
Search

Latest Stories

PSNC urges pharmacy team members to fill NHSX Data Strategy Survey

The Pharmaceutical Services Negotiating Committee (PSNC) has urged the pharmacy team members and Local Pharmaceutical Committee (LPCs) to complete the NHSX Data Strategy Survey and share their views about the use of health data and community pharmacy access to electronic health records.

The survey will close on Friday 20th August and takes around five minutes to complete, it said.


PSNC has already shared its views with the NHSX that:

  • Shared Care Record (ShCR) protocols, sign-up processes and technical standards should be standardised;
  • Information Governance protocols should not be excessive for pharmacy staff accessing ShCR or Summary Care Record (SCR) systems;
  • Integrated Care Systems (ICS) developing the ShCR systems in their area should engage with LPCs and pharmacy contractors about pharmacy access to ShCRs; and
  • Pharmacy professionals should have:
  • read and write access of the ShCR systems within their area; and
  • access to SCR with Additional Information after the pandemic.

The publication of the survey follows the Department of Health and Social Care’s draft policy paper about improving the use of health data: Data saves lives: reshaping health and social care with data.

The policy paper, published on July 28, envisages the use of data to improve patient care and save lives.

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less